Researchers sought to describe the experiences of neurologists caring for patients with neurodegenerative disorders in a community-based, outpatient setting during the COVID-19 pandemic.
Researchers assessed the impact of oral inosine, a metabolic precursor of urate, on disease progression in patients with early Parkinson disease.
Researchers sought to identify candidate casual genes for Parkinson disease by integrating the genome-wide association study results with large-scale expression quantitative trait loci in 13 brain tissues.
Researchers evaluated the safety and efficacy of oral levosimendan, a calcium sensitizer, in patients with amyotrophic lateral sclerosis, and its ability to maintain respiratory function.
Researchers sought to investigate clinical predictors of the effect of subthalamic nucleus-deep brain stimulation on impulsive and compulsive behaviors in patients with Parkinson disease.
Researchers investigated the effects of a strength training program on function, activity, and participation in children and adolescents with cerebral palsy.
Researchers evaluated the 1-year safety data on subcutaneous levodopa/carbidopa continuous infusion with ND0612, an investigational subcutaneous delivery system providing minimally invasive continuous infusion, in patients with Parkinson disease.
Researchers shared their findings on the relationship between metabolic factors, like blood markers of lipid and carbohydrate metabolism, and the risk of developing amyotrophic lateral sclerosis.
In a study presented at MDS 2021, researchers assessed the progression of spinocerebellar ataxias type 1, 2, 3, and 6, an autosomal dominantly inheritance, to identify factors that influence the transition to higher disability.
In a study presented at MDS 2021, researchers assessed whether patients with tic disorders with or without major psychoses were at risk of developing tardive dyskinesia.
